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Abstract
This article describes the practical approach to endoscopic treatment of peptic ulcer bleeding and Dieulafoy’s lesions
including theoretical considerations of importance for the outcome. Endoscopic therapy is indicated in ulcers with active
bleeding, a nonbleeding visible vessel, or an adherent clot. For high-risk ulcers (Forrest I–IIa), the authors of this article
recommend initial treatment with injection of diluted adrenaline followed by a second hemostatic therapy (heater probe or
clips). This article is part of an expert video encyclopedia.
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Materials
• Endoscope: Evis Exera GIF-H180 and Evis Exera GIF-
2T160; Olympus, Mt Waverley, Australia.
• Heater probe: HeatProbe CD-110U; Olympus, Mt Waverley,
Australia.
• Hemoclip: Resolution Clip M00522601; Boston Scientiﬁc,
Natick, MA, USA.
Background and Endoscopic Procedures
Peptic ulcer bleeding (PUB) is the most common source of
upper gastrointestinal bleeding. Performance of upper en-
doscopy is crucial in order to diagnose the bleeding source
and, in cases with high risk of adverse outcome, perform
endoscopic therapy.
In general, patients with suspected PUB should undergo
endoscopy within 24 h, which is shown to decrease the risk of
rebleeding, need for surgical hemostasis, and duration of
hospital stay.1 At endoscopy the mucosa of the esophagus,
stomach, and the duodenum is thoroughly visualized. In cases
where a peptic ulcer is found, the endoscopist should be able
to perform adequate risk stratiﬁcation based on the stigmata
of recent bleeding. This is often done using the Forrest clas-
siﬁcation (Table 1).2
Endoscopic therapy is not indicated in cases with Forrest
IIc–III ulcers as the risk of rebleeding is relatively low (r10%).3
In ulcers with an adherent clot (deﬁned as a clot resistant
to forceful irrigation or suction), the risk of rebleeding is
Z20%
if endoscopic therapy is not applied.3 In these cases, we rec-
ommend quadrant-wise injection of aliquots of 1 ml of dilu-
ted adrenaline (1:10 000) until a total of 5–10 ml is injected.
Following injection of diluted adrenaline, most clots are easily
removed using irrigation, suction, a biopsy forceps, or a snare
in case of larger clots. Following removal of the clot, the ulcer
base is inspected for signs of a visible vessel or active bleeding.
In patients with active bleeding from the ulcer base or a
nonbleeding visible vessel, performance of endoscopic ther-
apy is crucial in order to achieve hemostasis, reduce the risk of
rebleeding, need for surgical hemostasis, and mortality.4 The
authors prefer to use injection of diluted adrenaline, treatment
with heater probe, or application of clips.
Injection of diluted adrenaline is a good ﬁrst-line therapy
in order to achieve hemostasis and prevent rebleeding from
high-risk ulcers (Forrest I–IIa). The technique used is quad-
rant-wise injection of aliquots of 1–2 ml of diluted adrenaline
(1:10 000), as for ulcers with an adherent clot, but injection of
a total volume of 13–30 ml is recommended, as this is asso-
ciated with a lower rate of rebleeding compared to injection of
a lower total volume (o10 ml).5 Injection of more than 30 ml
of diluted adrenaline is not recommended due to increased
risk of perforation.6 It is preferable to avoid injection closer
than 2–3 mm from the bleeding point in order to reduce the
risk of intravascular injection and iatrogenic bleeding.
Table 1 Forrest classiﬁcation and associated risk of rebleeding
Forrest
score
Endoscopic appearance Risk of
rebleedinga
Ia Ulcer with active pulsating bleeding 55%
Ib Ulcer with active nonpulsating bleeding
IIa Ulcer with a visible nonbleeding vessel 43%
IIb Ulcer with an adherent clot 22%
IIc Ulcer with hematin on ulcer base 10%
III Ulcer with a clean base without signs of
recent bleeding
5%
aRisk of rebleeding if endoscopic therapy is not performed.
Source: Adapted from Laine, L.; Peterson, W. L. Bleeding Peptic Ulcer. N. Engl. J. Med.
1994, 331, 717–727.
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Monotherapy with injection of diluted adrenaline is associ-
ated with a high risk of rebleeding (19%).7 Therefore, the
authors recommend adding a second endoscopic method
(heater probe or clips), which is shown to reduce the rate of
rebleeding as well as need for surgical hemostasis.7
The advantage of the heater probe is its ability to achieve
coaptive coagulation. Use of a 10 F probe is recommended.
The heater probe is initially applied around the bleeding site
in order to stop the blood supply to the bleeding point. The
probe is applied using a ﬁrm tamponade in order to promote
coaptive coagulation. Three to four 30 J pulses should be de-
livered before irrigation and change of position. Finally, the
area of previous bleeding is coagulated. The endpoint of
treatment is a footprint at the site of the vessel. A meta-analysis
has suggested that monotherapy with heater probe is associ-
ated with a higher rebleeding rate compared with combined
therapy with diluted adrenaline.8 Consequently, combined
therapy with preceding injection of diluted adrenaline or ap-
plication of clips is recommended.
Clips are useful for both achieving hemostasis and pre-
venting recurrent bleeding from ulcers with protruding vessels.
In general, the clip should be held as close as possible to the
endoscope, as this enables the endoscopist to exert maximum
downward force on the clip during application and increases
the precision.9 Therefore, the endoscope should be placed close
to the bleeding site. When applying the hemoclip, it is placed
slightly away from the base of the artery in order to entrap the
immediately surrounding tissue. Once the clip is correctly
placed it is slowly closed. Simultaneous suction during appli-
cation of the clip can increase the capture. In some cases ap-
plication of several clips is needed in order to achieve
hemostasis. When applied correctly, monotherapy with clips
seems equally efﬁcient as endoscopic combination therapy.8,10
Key Learning Points/Tips and Tricks
• Endoscopy should be performed within 24 h in patients
with suspected PUB.
• Endoscopic treatment is indicated in ulcers with an ad-
herent clot, a visible nonbleeding vessel, or an active
bleeding.
• In most cases with adherent clots, the clot is easily moved
after injection of diluted adrenaline.
• After removal of an adherent clot the ulcer base is inspected
for bleeding stigmata indicating further treatment.
• Generally, for high-risk ulcers (Forrest I–IIa) initial treat-
ment is recommended with injection of 13–30 ml of
diluted adrenaline followed by a second hemostatic
therapy (heater probe or clips), although monotherapy
with clips might be equally efﬁcient.
Scripted Voiceover
Time
(min:sec)
Voiceover text
00:05 Peptic ulcer bleeding is the most common source of non-
variceal upper gastrointestinal bleeding.
00:21 In this patient an ulcer with an adherent clot was found in
the duodenal bulb.
00:30 An adherent clot is usually deﬁned as a clot resistant to
forceful irrigation or suction.
00:40 Ulcers with an adherent clot are classiﬁed as a IIb ulcer
according to the Forrest classiﬁcation.
00:50 These ulcers are associated with a rate of rebleeding
above 20% if endoscopic treatment is not performed.
01:00 Before proceeding to endoscopic therapy it is important to
check for other bleeding sources and gastric biopsies
should be taken as part of investigation of possible
H. pylori infection.
01:14 Regarding treatment we recommend quadrant-wise
injection of aliquots of 1 ml of diluted adrenaline.
01:27 When injecting diluted adrenaline the needle is inserted
about 3 mm from the bleeding point in order to avoid
intravasal injection.
01:51 The total volume injected depends on the type of ulcer.
02:00 In most ulcers with an adherent clot injection of a total
volume of 5–10 ml of diluted adrenaline is sufﬁcient.
02:10 By contrast, injection of a total volume between 13–30 ml
is recommended in ulcers with active bleeding, or a
visible non-bleeding vessel, in order to decrease the risk
of rebleeding.
02:28 Injection of more than 30 ml of diluted adrenaline is not
recommended due to increased risk of perforation.
02:44 Following injection of diluted adrenaline most clots are
easily removed using irrigation, suction, a biopsy
forceps or a snare in case of larger clots.
03:49 When the clot is removed the ulcer is inspected for active
bleeding, or signs of a non-bleeding vessel, requiring
further endoscopic therapy.
04:01 In this case there was minor active bleeding from the ulcer
base indicating the presence of an underlying artery.
04:10 In ulcers with active bleeding, or ulcers containing a non-
bleeding visible vessel, monotherapy with diluted
adrenaline is associated with a rebleeding rate around
20% and is therefore considered insufﬁcient.
04:28 Combined treatment with heater probe or hemoclips will
reduce the rate of rebleeding.
04:40 In this case we used the heater probe.
04:54 The heater probe is initially applied around the bleeding
site in order to stop the blood supply to the bleeding
point.
05:07 The heater probe is applied using a ﬁrm tamponade in
order to promote coaptive coagulation.
05:14 Three to four 30 J pulses should be delivered before
irrigation and change of position.
05:22 After treatment a footprint should be visible at the site of
the vessel.
05:28 A meta-analysis has indicated that monotherapy with
heater probe is associated with increased rebleeding
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rate compared to combined therapy with diluted
adrenaline.
05:38 Thus, we prefer to combine heater probe therapy with a
second endoscopic treatment.
05:44 In another patient a large ulcer containing a non-bleeding
vessel was found at the minor gastric curvature.
05:53 This type of ulcer is classiﬁed as a IIa ulcer according to
the Forrest classiﬁcation.
06:01 In protruding vessels a hemoclip is useful both to achieve
hemostasis and to prevent recurrent bleeding.
06:13 In general, the clip should be held as close to the
endoscope as possible as this enables the endoscopist
to exert maximum downward force on the clip during
application and increases precision.
06:30 The hemoclip is placed slightly away from the base of the
artery in order to entrap the immediately surrounding
tissue.
06:40 When the clip is correctly placed it is slowly closed and
released. Simultaneous suction during application of the
clip can increase the capture.
06:51 In some cases application of several clips is needed in
order to achieve hemostasis.
06:58 Monotherapy with clips seems to be equally efﬁcient to
endoscopic combination therapy.
07:04 In another patient a Dieulafoy’s lesion was found in the
lower esophagus.
07:25 In order to achieve hemostasis, injection of diluted
adrenaline was chosen as ﬁrst type of therapy.
07.57 Following injection of 2–3 ml of diluted adrenaline the
bleeding ceased.
08.03 In order to prevent recurrent bleeding a clip was applied at
the site of the lesion.
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